Lactobacillus reuteri ATCC 55730 and L22 display probiotic potential in vitro and protect against Salmonella-induced pullorum disease in a chick model of infection

Research in Veterinary Science

Volumn 93, Issue 1, 2012, Pages 366-373

  Zhang, Dexian ^a   Li, Rui ^a   Li, Jichang ^a  

^a NORTHEAST AGRICULTURAL UNIVERSITY   (China)

Author keywords

Antimicrobial activity; Lactobacillus reuteri ATCC 55730 and L22; Probiotics; Pullorum disease

Indexed keywords

BACITRACIN; BILE SALT; CHLORAMPHENICOL; CLOXACILLIN; PENICILLIN G; POLYPEPTIDE ANTIBIOTIC AGENT; PROBIOTIC AGENT; REUTERIN; STREPTOMYCIN; TEICOPLANIN; TETRACYCLINE; UNCLASSIFIED DRUG; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ANTIBIOSIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL SURVIVAL; CHICK; CONTROLLED STUDY; ESCHERICHIA COLI; ESCHERICHIA COLI O78; GROWTH CURVE; GROWTH INHIBITION; HEMAGGLUTINATION TEST; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; LACTOBACILLUS REUTERI; LIQUID CULTURE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PH; PROTECTION; PULLORUM DISEASE; SALMONELLA GALLINARUM; STRAIN DIFFERENCE; SURVIVAL RATE;

ANIMALS; ANTI-BACTERIAL AGENTS; CHICKENS; DRUG RESISTANCE, BACTERIAL; FEMALE; GLYCERALDEHYDE; HEMAGGLUTINATION TESTS; LACTOBACILLUS REUTERI; MALE; POULTRY DISEASES; PROBIOTICS; PROPANE; SALMONELLA; SALMONELLA INFECTIONS, ANIMAL;

ANIMALIA; ESCHERICHIA COLI; LACTOBACILLUS REUTERI; SALMONELLA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR PULLORUM;

EID: 84861481907     PISSN: 00345288     EISSN: 15322661     Source Type: Journal    
DOI: 10.1016/j.rvsc.2011.06.020     Document Type: Article

References (50)

1. Adolfsson O., Meydani S.N., Russell R.M. Yogurt and gut function. American Journal of Clinical Nutrition 2004, 80:245-256.
2. Aiba Y., Suzuki N., Kabir A.M.A., Tagaki A., Koga Y. Lactic acid mediated suppression of Helicobacter pylori by the oral administration of Lactobacillus salivarious as a probiotic in a gnotobiotic murine model. American Journal of Gastroenterology 1998, 93:2097-2101.
3. Andreu A., Stapleton A.E., Fennell C.L., Hillier S.L., Stamm W.E. Hemagglutination, adherence, and surface properties of vaginal Lactobacillus species. Journal of Infectious Disease 1995, 171:1237-1243.
4. Aminov R.I., Garrigues-Jeanjean N., Mackie R.I. Molecular ecology of tetracycline resistance. development and validation of primers for detection of tetracycline resistance genes encoding ribosomal protection proteins. Applied Environmental Microbiology 2001, 67:22-32.
5. Axelsson L., Chung T.L., Dobrogosz W.J. Production of a broad-spectrum antimicrobial substance by Lactobacillus reuteri. Microbial Ecology Health and Disease 1989, 2:131-136.
6. Atanassova M., Choiset Y., Dalgalarrondo M., Chobert J.M., Dousset X., Ivanova I. Isolation, partial biochemical characterization of a proteinaceous anti-bacteria, anti-yeast compound produced by Lactobacillus paracasei subsp. paracasei strain 55730. International Journal of Food Microbiology 2003, 87:63-73.
7. Barbosa T.M., Scott K.P., Flint H.J. Evidence for recent intergeneric transfer of a new tetracycline resistance gene, tet (W), isolated from Butyrivibrio fibrisolvens, and the occurrence of tet (O) in ruminal bacteria. Applied Environmental Microbiology 1999, 1:53-64.
8. Bernet-Camard M.F., Lievin V., Brassart D., Neeser J.R., Servin A.L., Hudault S. The human Lactobacillus acidophilus strain LA1 secretes a nonbacteriocin antibacterial substance(s) active in vitro and in vivo. Applied Environmental Microbiology 1997, 63:2747-2753.
9. Caglar E., Kavaloglu Cildir S., Ergeneli S., Sandalli N., Twetman S. Salivary mutans streptococci and lactobacilli levels after ingestion of the probiotic bacterium Lactobacillus reuteri ATCC 55730 by straws or tablets. Acta Odontol Scand 2006, 64:314-318.
10. Casas I.A., Dobrogosz W.J. Validation of the probiotic concept: Lactobacillus reuteri confers broad-spectrum protection against disease in humans and animals. Microbial Ecology Health and Disease 2000, 12:257-285.
11. Chou L., Weimer B. Isolation and characterisation of acid and bile-tolerant isolates from strains of Lactobacillus acidophilus. Journal of Dairy Science 1999, 82:23-31.
12. Christensen H.R., Frokiaer H., Pestka J. Lactobacilli differentially modulate expression of cytokines and maturationsurface markers in murine dendritic cells. Journal of Immunology 2002, 168:171-178.
13. Cleusix V., Lacroix C., Vollenweider S., Duboux M., Le B.G. Inhibitory activity spectrum of reuterin produced by Lactobacillus reuteri against intestinal bacteria. BMC Microbiology 2007, 7:101.
14. Danielsen M., Wind A. Susceptibility of Lactobacillus spp. to antimicrobial agents. International Journal of Food Microbiology 2003, 82:1-11.
15. Toit D.M., Franz C.M.A.P., Dicks L.M., Holzapfel W.H. Preliminary characterization of Bacteriocin produced by Enterococcus faecium and Enterococcus faecalis isolated from pig faeces. Journal of Applied Microbiology 2000, 88:482-494.
16. Ennahar S., Aoude-Werner D., Assobhei O., Hasselmann C. Antilisterial activity of enterocin 81, a bacteriocin produced by Enterococcus faecium WHE 81 isolated from cheese. Journal of Applied Microbiology 1998, 85:521-526.
17. Fernández M.F., Boris S., Barbés C. Probiotic properties of human lactobacilli strains to be used in the gastrointestinal tract. Journal of Applied Microbiology 2003, 94:449-455.
18. Food and Agriculture Organization of the United Nations/World Health Organization. Guidelines for the evaluation of probiotics in food. Report of a Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food. London, Ontario, Canada: FAO/WHO; 2002.
19. Fuller R. Probiotics. Applied Bacteriology, Symposium Supplement 1986, 1S-7S.
20. Fuller R. Probiotics in man and animals. Journal of Applied Bacteriology 1989, 66:365-378.
21. Gunn J.S. Mechanisms of bacterial resistance and response to bile. Microbes and Infection 2000, 2:907-913.
22. Hammilton-Miller J.M.T. The role of probiotics in the treatment and prevention of H. Pylori infection. International Journal of Antimicrobial Agents 2003, 22:360-366.
23. Hart A.L., Lammers K., Brigidi P., Vitali B., Rizello F., Gionchetti P., Campieri M., Kamm M.A., Knight S.C., Stagg A.J. Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut 2004, 53:1602-1609.
24. Hofmann, A., 1991. Enterohepatic circulation of bile acids. In: Schultz, S.G., Forte, J.G., Rauner, B.B. (Eds.), Handbook of Physiology Section 6: the gastrointestinal system. vol. 3, pp. 567-580.
25. Klarin B., Johansson M.L., Molin G., Larsson A., Jeppsson B. Adhesion of the probiotic bacterium Lactobacillus plantarum 299v onto the gut mucosa in critically ill patients: a randomised open trial. Critical Care 2005, 9:R285-R293.
26. Kociubinsky G., Pérez P., Antoni D.G. Screening of bile resistance and bile precipitation in Lactic Acid Bacteria and Bifidobacteria. Journal of Food Protection 1999, 62:905-912.
27. Spinler J.K., Malai T., Cheryl L.R., Ching N.Ou, Somying T., James V. Human-derive probiotic Lactobacillus reuteri demonstrate antimicrobial activities targeting diverse enteric bacterial pathogens. Anaerobe 2008, 14:166-171.
28. Maragkoudakis P.A., Zoumpopoulou G., Miaris C., Kalantzopoulos G., Pot B., Tsakalidou E. Probiotic potential of Lactobacillus strains isolated from dairy products. Inernational Dairy Journal 2006, 16:189-199.
29. Pinto M.G.V., Charles M.A.P., Franz C.M., Schillinger U., Holzapfel W.H. Lactobacillus spp. with in vitro probiotic properties from human faeces and traditional fermented products. International Journal of Food Microbiology 2006, 109:205-214.
30. Bernardeau M., Gueguen M., Smith D.G.E., Corona-Barrera E., Vernoux J.P. In vitro antagonistic activities of Lactobacillus spp. against Brachyspira hyodysenteriae and Brachyspira pilosicoli. Veterinary Microbiology 2009, 138:184-190.
31. Mathur S., Singh R. Antibiotic resistance in food lactic acid bacteria-a review. International Journal of Food Microbiology 2005, 105:281-295.
32. Mercenier A., Pavan S., Pot B. Probiotics as biotherapeutic agents: present knowledge and future prospects. Current Pharmaceutical Design 2003, 9:175-191.
33. El-Ziney M.G., Arneborg N., Uyttendaele M., Debevere J., Jakobsen M. Characterization of growth and metabolite production of Lactobacillus reuteri during glucose/glycerol cofermentation in batch and continuous cultures. Biotechnology Letters 1998, 20:913-916.
34. Mitsuoka T. The human gastrointestinal tract. Lactic acid bacteria in health and disease 1992, vol. 1:76. Elsevier, London.
35. Molin G. Probiotics in foods not containing milk or milk constituents, with special reference to Lactobacillus plantarum 299v. The American Journal of Clinical Nutrition 2001, 73:380-385.
36. Nollet L.J.A., Pereira D.I., Verstraete W. Effect of a probiotic bile salt hydrolytic Lactobacillus reuteri on the human gastrointestinal microbiota as simulated in the SHIME reactor system. Microbes Ecology Health and Disease 1999, 11:13-21.
37. O'Mahony A., O'Sullivan T., Walsh Y., Vaughan A., Maher M., Fitzgerald G.F., Van Sinderen D. Characterization of antimicrobial producing lactic acid bacteria from malted barley. Journal of Institure of Brewing 2000, 106:403-410.
38. Parente E., Ricciardi A. Production, recovery and purification of bacteriocins from lactic acid bacteria. Applied Microbiology and Biotechnology 1999, 52:628-638.
39. Parvez S., Malik K.A., Ah Kang S., Kim H.Y. Probiotics and their fermented food products are beneficial for health. Journal of Applied Microbiology 2006, 100:1171-1185.
40. Rosander A., Connolly E., Roos S. Removal of antibiotic resistance gene-carrying plasmids from Lactobacillus reuteri ATCC 55730, characterization of the resulting daughter strain, L. reuteri DSM 17938. Applied and Environmental Microbiology 2008, 74:6032-6040.
41. Scott K.P., Melville C.M., Barbosa T.M., Flint H.J. Occurrence of the new tetracycline resistance gene tet (W) in bacteria from the human gut. Antimicrobial Agents and Chemother 2000, 44:775-777.
42. Servin A.L. Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiology Reviews 2004, 28:405-440.
43. Sgouras D., Maragkoudakis P., Petraki K., Martinez-Gonzalez B., Eriotou E., Michopoulos S., Kalantzopoulos G., Tsakalidou E., Mentis A. In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei strain Shirota. Applied and Environmental Microbiology 2004, 70:518-526.
44. Chung T.C., Axelsson L., Lindgren S.E., Dobrogosz W.J. In vitro studies on reuterin synthesis by Lactobacillus reuteri. Microbial Ecology in Health and Disease. 1989, 2:137-144.
45. Talarico T.L., Casas I.A., Chung T.C. Production and isolation of reuterin, a growth inhibitor produced by Lactobacillus reuteri. Antimicrobial Agents and Chemother 1988, 32:1854-1858.
46. Tannock G.W., Dashkevitz M.P., Feighner S.D. Lactobacilli and bile salt hydrolase in the murine intestinal tract. Applied Environmental Microbiology 1989, 55:1848-1851.
47. Villedieu A., az-Torres M.L., Hunt N., McNab R., Spratt D.A., Wilson M., Mullany P. Prevalence of tetracycline resistance genes in oral bacteria. Antimicrobial Agents and Chemother 2003, 47:878-882.
48. Vollenweider S., Grassi G., Konig I., Puhan Z. Purification and structural characterization of 3-hydroxypropionaldehyde and its derivatives. Journal of Agricultural Food Chemistry 2003, 51:3287-3293.
49. Zani J.L. Effect of probiotic CenBiot on the control of diarrhea and feed efficiency in pigs. Journal of Applied Microbiology 1998, 84:68-71.
50. Zárate G., Pérez C.A., González S., Oliver G. Viability and β-galactosidase activity of diary propionibacteria subjected to digestion by artificial gastric and intestinal fluids. Journal of Food Protetion 2000, 63:1214-1221.